To all articles

Investor presentation: Unlocking the power of the proteome to revolutionize biomedicine

Nautilus Biotechnology

September 18, 2025

Nautilus Co-Founder and CEO Sujal Patel joined CFO Anna Mowry at the Q3 Investor Summit Group Virtual Conference to share why the world needs the Nautilus Platform to vastly improve drug development and usher in a new era of precision medicine. Watch the presentation to discover why we’re excited to redefine proteomics with a complete solution designed to confidently quantify the entire proteome and its myriad proteoforms with unbeatable reproducibility, accuracy, precision, and single-molecule sensitivity.

Watch the presentation

Share this Article

Stay up-to-date on all things Nautilus

World-class articles, delivered weekly

Subscribe

MORE ARTICLES

Nautilus: Driving a revolution in proteomic analysis

New protein sequencing technology from Nautilus is unlocking the proteome and igniting a proteomics revolution.

A brief introduction to PrISM – The theoretical framework underpinning the Nautilus platform

Learn about Protein Identification by Short epitope Mapping (PrISM) - The theoretical framework underpinning the Nautilus Platform.

Nautilus: Driving a revolution in proteomic analysis (Part 2)

We give you an inside view on how cross-disciplinary thinking and collaboration will propel us into a proteomics-powered future.

View all articles

Stay up-to-date on all things Nautilus

Subscribe to our Newsletter

Subscribe